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Simply MArvelous nuclear transport
HIV-1 MA protein is a viral membrane protein, but it is also involved in
nuclear import of the preinitiation complex; the latter requires transfer of
some MA molecules to the maturing core particle during virus assembly.
Human immunodeficiency virus 1 (HIV-1) is a complex
retrovirus that employs genetic and cell biological stra-
tegies not known to be associated with simple retro-
viruses. Two of these strategies involve adept use of the
host cell's nuclear transport apparatus. In one case, the
HIV-1 Rev protein exercises control over RNA export
during virus replication [1,2], and in the second case viral
proteins, including the matrix protein (MA), direct the
nuclear import of the viral preintegration complex dur-
ing infection. The precise mechanism by which the MA
protein directs nuclear transport of the viral genome will
be difficult to ascertain, because its action is inextricably
linked to subtle features of the viral membrane and inter-
nal structure, which change during maturation and along
the intracellular pathway of infection.
As was first shown for visna virus [3], HIV-1 and the
other lentiviruses can infect both dividing and non-divid-
ing cells [4,5]. During the course of infecting non-divid-
ing cells, the HIV-1 preintegration complex is actively
transported across the intact interphase nuclear envelope
[6]. The nuclear import of HIV-1 preintegration com-
plexes was found to be inhibitable during infection by
the addition of synthetic nuclear localization signal (NLS)
peptides derived from simian virus 40 (SV40) large T-
antigen to the tissue culture cell medium [7]. This obser-
vation suggests that the HIV-1 preintegration complex is
imported via the cell's predominant transport pathway,
and that it must compete with cellular nuclear traffic for
saturable transport factors [8].
In contrast to the lentiviruses, the oncoretrovirus murine
leukemia virus (MuLV) is unable to infect non-dividing
cells [6,9]. The favoured hypothesis to explain this repli-
cation barrier is that the MuLV preintegration complex
lacks functional NLSs, and thus depends on a mitotic
cycle of nuclear envelope breakdown and assembly to
gain access to the host genome [6,9]. Because there is con-
siderable diversity among oncoretroviruses, it is possible
that some non-lentiviruses produce karyophilic (nucleus-
seeking) preintegration complexes that are blocked after
nuclear transport, for example, prior to integration.
Sadly, though, it is the capacity of HIV-1 to integrate and
replicate in non-dividing cells that leads to infections of
terminally differentiated macrophages and neuroglia cells,
defining events in the unique pathology of human AIDS.
In the past two years, significant advances have been
made in our understanding of HIV-1 nuclear transport.
Most recently, Gallay et al. [10] have proposed that
phosphorylation of the 17kD MA protein plays a key
role in the establishment of the karyophilic HIV-1 pre-
integration complex. The MA proteins of both simple
and complex retroviruses, which are initially translated as
polyproteins encoded by the viral gag gene, are closely
associated with the viral membrane - thousands of MA
polypeptides are anchored in the inner leaflet of the viral
membrane by amino-terminal myristoyl groups. On the
face of it, this membrane association is difficult to recon-
cile with MA having a role in the nuclear transport of the
membrane-free HIV-1 preintegration complex.
MA is essential for the assembly of nascent HIV-1 viri-
ons, but it was thought that this requirement was attri-
butable to its roles in targeting the rest of the gag
polyprotein to the membrane before its release by prote-
olytic processing, and in recruiting the envelope glyco-
protein (Gp120 and Gp41) to the plasma membrane.
Immunogold electron microscopic analysis indicated that
MA covers the spherical interior surface of the viral
membrane, whereas the core-associated protein (CA),
which dissociates prior to formation of the preintegration
complex, coats the triangular shell of the core particle
[11]. Furthermore, the bulk of MA is always recovered
from cytoplasmic membrane fractions (see [10]). It was
thus surprising to learn that HIV-1 preintegration com-
plexes that fractionated from cell extracts with nuclei
contained some MA in addition to the viral genome,
reverse transcriptase and integrase [12]. A model for the
role of MA in the nuclear transport of the HIV-1 prein-
tegration complex during infection is shown in Figure 1.
The earliest indication that MA directly participates in
the nuclear transport of the HIV-1 preintegration com-
plex came from studies showing, first, that MA contains
an NLS capable of targeting microinjected reporter pro-
teins to the nuclei of tissue culture cells [13], and, second,
that viruses with mutations of the MA NLS can be prop-
agated in dividing cells but not in cell-cycle-arrested cells
[13,14]. The latter studies used HIV-1 strains that lacked
the auxiliary gene, vpr. Subsequently, it was shown that
the Vpr protein itself contains an NLS that is sufficient
for HIV-1 import in an HIV-1 strain containing a defec-
tive MA NLS [15]. Thus, MA and Vpr contain redun-
dant NLSs that are sufficient but not necessary for HIV-1
nuclear transport. The vpr gene is not, however, essential
for infection, replication or the development of AIDS in
rhesus monkeys infected with SIV [16], and a number of
the studies on HIV-1 nuclear transport use infectious
HIV-1 strains lacking a vpr gene. It remains to be seen
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Fig. 1. Proposed role of the MA protein in nuclear transport of the HIV-1 preintegration complex.
whether other proteins of the HIV-1 preintegration
complex contain NLSs that fractionally stimulate the rate
of nuclear transport. These initial studies left unresolved
the intriguing question of how MA can both comprise a
major part of the viral membrane and direct the nuclear
transport of the membrane-free preintegration complex.
This dilemma was recently addressed by Gallay et al. [101,
who first confirmed that a subset of MA molecules con-
tain phosphoserine and phosphotyrosine, and went on to
show that it is this population of MA proteins that is
imported into nuclei during infection. Interestingly, the
MA proteins in this population also contained myristoyl
groups, suggesting that they had at one time been attach-
ed to the membrane. Previous studies on other myris-
toylated proteins, showing that they could be released
from the plasma membrane following phosphorylation
[17,18], provided the rationale for the hypothesis that
phosphorylation of MA triggers its transfer from the
membrane to the maturing core during virus assembly
(Fig. 2). This hypothesis predicts that, during virus
assembly, - 1 % of MA polypeptides are transferred into
the core particle, while the remaining - 99 % remain
associated with the incipient viral membrane.
To investigate the role of MA tyrosine phosphorylation
in this partitioning process, Gallay et al. [10] systematica-
lly substituted the three MA tyrosines (Y) with phenyl-
alanines (F), and tested the effects of the mutations on
the production of infectious virus particles. The results
showed that tyrosine residue Y132 is the target of a puta-
tive cellular kinase. MA tyrosine phosphorylation occur-
red in the absence of other viral proteins, but only if MA
was anchored to the plasma membrane either by its
myristoyl group or by fusion to the cytoplasmic domain
of CD4 (the plasma membrane receptor for HIV-1). This
result, together with the observation that nuclear MA
contains phosphotyrosine, supports the hypothesis that
the MA-gag polyprotein is first inserted into the plasma
membrane, proteolytically processed, phosphorylated,
and only then transferred to the core.
The association of NLS-containing MA proteins with
what will develop into the preintegration complex dur-
ing subsequent infections is thus established during virus
maturation. Although tyrosine phosphorylation of MA
correlates with its nuclear transport, and MA was previ-
ously shown to be associated with nuclear forms of the
preintegration complex [12], the physical association of
MA with the core particle in the mature virus is so far
only implied, not proven. Curiously, Gallay et al. [10]
find tyrosine kinase activity associated with mature virus.
Whether this kinase is merely trapped in the virus after
MA transfer is completed, or, alternatively, continues to
act on MA within the mature virus not known.
The model illustrated in Figure 1 predicts that MA trans-
fer is dependent on tyrosine phosphorylation and that, in
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Fig. 2. MA-related aspects of HIV-1 assembly.
the absence of phosphorylation, the inchoate preintegra-
tion complex will not receive the complement of MA
NLSs it needs to cross the nuclear envelope. In fact,
mutant virus with the Y132F MA mutation could be
propagated in dividing cells, but not in non-dividing cells.
This result shows that Y132 phosphorylation is required
for the formation of a potent karyophilic HIV-1 preinte-
gration complex. But while the Y132F mutation com-
pletely inhibited replication of the virus in non-dividing
cells, the absence of tyrosine phosphorylation did not
completely abolish the formation of viral DNA circles
that occurs only after import of the preintegration com-
plex into the nucleus. It is conceivable that, in the absence
of Y132 phosphorylation, a small number of MA proteins
are still transferred into the maturing core, and these are
sufficient to support a limited degree of nuclear transport
in non-dividing cells, but not enough for the virus to
mount a productive infection.
Gallay et al. [10] point out that serine phosphorylation of
MA, which persists in the Y132F mutant, could promote
the transfer of a few MA proteins to the viral core. The
relative contributions of tyrosine and serine phosphoryla-
tion of MA to its function in nuclear import are key to
our understanding of how HIV-1 infects non-dividing
cells. Future studies of the metabolism of MA during virus
assembly will have to focus attention directly on the role
of MA serine phosphorylation. Once all the factors that
contribute to MA transfer are known, the next question
will be the nature and timing of the regulatory mechanism
that determines how many molecules of MA are trans-
ferred from the membrane to the core. These issues, and
those pertaining to the disposition of the myristoyl group
and the MA NLS in the karyophilic preintegration com-
plex, will be addressed by biochemical studies of viral core
particles and cytoplasmic preintegration complexes.
Now that several basic features of the molecular mech-
anism of HIV-1 nuclear transport have been revealed,
broader questions about the role of viral nuclear transport
in the development of AIDS pathology, viral latency and
rates of propagation can be investigated. Future research
will have to focus on HIV-1 nuclear transport in animal
models, where assessments of host invasion and the estab-
lishment of the virus in different tissues can be made
under physiological conditions. Lastly, these insights into
the mechanism of HIV-1 nuclear transport, together with
the curious observation that synthetic NLS peptides can
inhibit HIV-1 replication in growth-arrested tissue cul-
ture cells by interfering with its nuclear transport [7], sug-
gest that the nuclear transport of HIV-1 may be a viable
target of future vaccines and anti-HIV-1 drugs [19].
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will include the following reviews, edited by Dani Bolognesi and Max Cooper, on Immunodeficiency:
Immune responses in HIV exposed seronegatives: have they repelled the virus?
by S.L. Rowland-Jones and A. McMichael
Are HIV-specific CTL responses salutory or pathogenic? by R.M. Zinkernagel
The immunology of primary HIV infection: which immune responses control HIV replication?
by J.T. Safrit and R.A. Koup
T lymphocyte receptor deficiences by DJ. Kappes, B. Alarc6n and J.R. Regueiro
Targets for autosomal SCID mutations by G.E. Taccioli and EW. Alt
Gene therapy for immunodeficiencies by M. Blaese
The same issue will also include the following reviews on Immunity to Infection,
edited by Alan Sher and Rafi Ahmed:
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Immunogenetics of intracellular infection by E. Skamene, D. Arbuckle and R. McLeod
The protective immune response to Mycobacterium tuberculosis by A.M. Cooper andJ.L. Flynn
Immunopathogenesis of chronic hepatitis C virus infection by C. Walker and C. Rice
Induction of Th2 responses in infectious diseases by E.J. Pearce and S.L. Reiner
IL-2 effects on immune responses to microbial infections: a key mediator in regulating
disease outcome by C.A. Biron and R.T. Gazzinelli
Cytokine regulation of granuloma formation in schistosomiasis by T.A. Wynn and A.W Cheever
Mechanisms of resistance to fungal infections by L. Romani and D.H. Howard
Viral mutations, T-cell receptor antagonism and escape from the immune response
by A. Franco, C. Ferrari, A. Sette and EV. Chisari
Entry of microbes into the host: using M cells to break the mucosal barrier
by B. Jones, L. Pascopella and S. Falkow
